VRK-IN-1
Product Specifications
UNSPSC Description
VRK-IN-1 is a potent and selective inhibitor of vaccinia-related kinases 1 (VRK1), with an IC50 of 150 nM. VRK1 is human Ser/Thr protein kinases associated with increased cell division and neurological disorders[1].
Target Antigen
Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/vrk-in-1.html
Purity
99.47
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC1=C(O)C(F)=CC(C2=C(C)N=CC(C3=CC(F)=C(O)C(F)=C3)=C2)=C1
Molecular Weight
349.28
References & Citations
[1]Serafim RAM, et, al. Development of Pyridine-based Inhibitors for the Human Vaccinia-related Kinases 1 and 2. ACS Med Chem Lett. 2019 Aug 19;10(9):1266-1271.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-126542/VRK-IN-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-126542/VRK-IN-1-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2378855-09-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1314103-01 0.02 mg (E-Coli)
Recombinant Oryza sativa subsp. japonica Probable calcium-binding protein CML25/26 (CML25)
Ask
View Details 
MBS1314103-02 0.1 mg (E-Coli)
Recombinant Oryza sativa subsp. japonica Probable calcium-binding protein CML25/26 (CML25)
Ask
View Details MBS1314103-03 0.02 mg (Yeast)
Recombinant Oryza sativa subsp. japonica Probable calcium-binding protein CML25/26 (CML25)
Ask
View Details MBS1314103-04 0.1 mg (Yeast)
Recombinant Oryza sativa subsp. japonica Probable calcium-binding protein CML25/26 (CML25)
Ask
View Details